![Dennis Mulroy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Mulroy
Director of Finance/CFO at
ARCTURUS THERAPEUTICS HOLDINGS INC.
Net worth: 692 332 $ as of 30/09/2026
Profile
Mr. Dennis M.
Mulroy, CPA, is a Chief Financial Officer at Arcturus Therapeutics Holdings, Inc. Mr. Mulroy was previously employed as a Chief Financial Officer by AnaptysBio, Inc., a CEO, Chief Financial & Accounting Officer by La Jolla Pharmaceutical Co., a Chief Financial Officer, Treasurer & Director by Tissue Repair Co., a Chief Financial Officer by Post-Hypothermia Corp., a Chief Financial Officer by Aries Ventures, Inc., a Chief Financial Officer by Gene Biotherapeutics, Inc., a Chief Financial Officer by Molecular Imaging Corp., a Chief Financial Officer by SeraCare Life Sciences, Inc., and a Chief Financial Officer by Bioceutix, Inc. He received his undergraduate degree from the University of San Diego.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANAPTYSBIO, INC. 0.05% | 01/06/2026 | 13,775 ( 0.05% ) | 692 332 $ | 30/09/2026 |
Dennis Mulroy active positions
| Companies | Position | Start |
|---|---|---|
| ARCTURUS THERAPEUTICS HOLDINGS INC. | Director of Finance/CFO | 01/05/2026 |
Former positions of Dennis Mulroy
| Companies | Position | End |
|---|---|---|
| ANAPTYSBIO, INC. | Director of Finance/CFO | 20/04/2026 |
| LA JOLLA PHARMACEUTICAL COMPANY | Chief Executive Officer | 31/05/2020 |
Taxus Cardium Pharmaceuticals Group, Inc.
 Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Director of Finance/CFO | 03/04/2015 |
Tissue Repair Co.
 Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Director of Finance/CFO | 02/01/2013 |
Aries Ventures, Inc.
 Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Director of Finance/CFO | 23/01/2006 |
Education of Dennis Mulroy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
60
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes patients life-threatening conditions | Health Technology |
Aries Ventures, Inc.
Aries Ventures, Inc. Financial ConglomeratesFinance Financial investment vehicle | Finance |
Molecular Imaging Corp.
 Molecular Imaging Corp. Medical/Nursing ServicesHealth Services Provides molecular imaging services | Health Services |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops and manufactures biological based products to serve the global life sciences industry | Health Technology |
Tissue Repair Co.
Tissue Repair Co. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops wound healing products for chronic wounds and aftercare | Health Technology |
AnaptysBio, Inc.
 AnaptysBio, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company | Health Technology |
University of San Diego
 University of San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Post-Hypothermia Corp.
 Post-Hypothermia Corp. Medical SpecialtiesHealth Technology Manufactures and markets temperature modulation therapy devices | Health Technology |
Taxus Cardium Pharmaceuticals Group, Inc.
Taxus Cardium Pharmaceuticals Group, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes angiogenic gene therapy products for cardiovascular disease | Health Technology |
Bioceutix, Inc. | |
Arcturus Therapeutics Holdings, Inc.
 Arcturus Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Dennis Mulroy
